现代汽车明年在中国推出豪车品牌捷尼赛思
现代汽车透露,中国消费者对大型汽车和豪车品牌的需求日益增加,将於明年在中国正式推出豪车品牌捷尼赛思(Genesis),并将於11月的中国国际进口博览会上介绍新车。
现代汽车表示,受疫情影响,原定於上半年推出新款「索纳塔」和「伊兰特」的计划推迟至下半年,加上中国市场竞争更加激烈,第三季度批发销量按年减少32%至30万辆。
集团计划,明年上半年於中国推出新一代「名图」和「途胜」,下半年推出多用途汽车「KU」和电动车品牌IONIQ系列的首款车型「NE」。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.